In this Q&A, Krishna Cheriath, VP and head of clinical research digital data and AI at Thermo Fisher Scientific, examines how ...
In today's ACT Brief, we examine why expanding governance layers slow digital modernization initiatives, how AI will augment ...
Angela Zubel, chief development officer at Debiopharm, framed 2026 as an implementation year—the moment when AI tools move from pilot programs into meaningful daily operations across drug development.
Pharma modernization initiatives stall not from lack of ambition but from expanding governance layers that distance ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
Kole identified workflow guidance as the most underaddressed gap in current eClinical ecosystems, arguing that technology has ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results